Glenstar Minerals
CSE-GSTR
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#42098
Market Cap
5.71 M
Volume
359.36
Price
0.26
Change (%)
9.09%
Country or region
Canada
Canada
Glenstar Minerals's latest marketcap:
5.71 M
As of May 14, 2025, Glenstar Minerals's market capitalization has reached $5.71 M. According to our data, Glenstar Minerals is the 42098th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.71 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -458,135.22 |
| Shares Out | 24.08 M |
| EPS (ttm) | -0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 14, 2025 |
Market Cap Chart
Data Updated: May 14, 2025
Glenstar Minerals's yearly market capitalization.
Glenstar Minerals has seen its market value grow from C$7.10 M to C$7.95 M since 2024, representing a total increase of 11.86% and an annual compound growth rate (CAGR) of 30.60%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 14, 2025 | C$7.95 M | 8.47% |
| December 12, 2024 | C$7.10 M |
Company Profile
Frequently Asked Questions
As of May 14, 2025, Glenstar Minerals (including the parent company, if applicable) has an estimated market capitalization of $5.71 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Glenstar Minerals global market capitalization ranking is approximately 42098 as of May 14, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | Canada |
| Founded | 2020 |
| IPO Date | n/a |
| Employees | n/a |
| CEO | |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Address |